DOI:
10.1055/s-00030576
Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics
LinksClose Window
References
Swift S, Garely A, Dimpfl T, Payne C ; Tolterodine Study Group.
A new once-daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder.
Int Urogynecol J Pelvic Floor Dysfunct 2003;
14 (1) 50-54 , discussion 54–55
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.